357 related articles for article (PubMed ID: 11992240)
21. [Progress on TTP/HUS diagnosis with analysis of VWF-cleaving protease activation].
Fujimura Y
Nihon Naika Gakkai Zasshi; 2004 Mar; 93(3):451-9. PubMed ID: 15052802
[No Abstract] [Full Text] [Related]
22. von Willebrand factor-cleaving protease in childhood diarrhoea-associated haemolytic uraemic syndrome.
Hunt BJ; Lämmle B; Nevard CH; Haycock GB; Furlan M
Thromb Haemost; 2001 Jun; 85(6):975-8. PubMed ID: 11434704
[TBL] [Abstract][Full Text] [Related]
23. Acquired deficiency of von Willebrand factor-cleaving protease in a patient with thrombotic thrombocytopenic purpura.
Furlan M; Robles R; Solenthaler M; Lämmle B
Blood; 1998 Apr; 91(8):2839-46. PubMed ID: 9531594
[TBL] [Abstract][Full Text] [Related]
24. [Hemolytic uremic syndrome and thrombotic thrombocytopenic purpura].
Masset C; Dubois B; Rorive G
Rev Med Liege; 2002 Jan; 57(1):33-9. PubMed ID: 11899496
[TBL] [Abstract][Full Text] [Related]
25. Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura.
Furlan M; Robles R; Solenthaler M; Wassmer M; Sandoz P; Lämmle B
Blood; 1997 May; 89(9):3097-103. PubMed ID: 9129011
[TBL] [Abstract][Full Text] [Related]
26. Plasma levels of the von Willebrand factor-cleaving protease in physiological and pathological conditions in children.
Kavakli K; Canciani MT; Mannucci PM
Pediatr Hematol Oncol; 2002; 19(7):467-73. PubMed ID: 12217192
[TBL] [Abstract][Full Text] [Related]
27. [Measurement of plasma von Willebrand factor cleaving protease in patients with varied thrombotic microangiopathy].
Katagiri H; Kawai Y; Sugizaki N; Sakai K; Handa M; Okamoto S; Watanabe K
Rinsho Byori; 2003 Jun; 51(6):516-21. PubMed ID: 12884737
[TBL] [Abstract][Full Text] [Related]
28. Von Willebrand factor-cleaving protease and Upshaw-Schulman syndrome.
Fujimura Y; Matsumoto M; Yagi H; Yoshioka A; Matsui T; Titani K
Int J Hematol; 2002 Jan; 75(1):25-34. PubMed ID: 11843286
[TBL] [Abstract][Full Text] [Related]
29. [Clinical features and laboratory findings of thrombotic thrombocytopenic purpura associated with ticlopidine].
Yagi H
Rinsho Byori; 2005 Jul; 53(7):630-8. PubMed ID: 16104532
[TBL] [Abstract][Full Text] [Related]
30. [Thrombotic thrombocytopenic purpura in children -- pathophysiologic mechanisms and their clinical significance].
Korczowski B
Med Wieku Rozwoj; 2005; 9(4):753-61. PubMed ID: 16733283
[TBL] [Abstract][Full Text] [Related]
31. Thrombotic thrombocytopenic purpura.
Lämmle B; Kremer Hovinga JA; Alberio L
J Thromb Haemost; 2005 Aug; 3(8):1663-75. PubMed ID: 16102032
[TBL] [Abstract][Full Text] [Related]
32. von Willebrand factor-cleaving protease inhibitor in a patient with human immunodeficiency syndrome-associated thrombotic thrombocytopenic purpura.
Sahud MA; Claster S; Liu L; Ero M; Harris K; Furlan M
Br J Haematol; 2002 Mar; 116(4):909-11. PubMed ID: 11886400
[TBL] [Abstract][Full Text] [Related]
33. Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/ thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other?
Shibagaki Y; Fujita T
Hypertens Res; 2005 Jan; 28(1):89-95. PubMed ID: 15969259
[TBL] [Abstract][Full Text] [Related]
34. ADAMTS13 and TTP.
Zheng X; Majerus EM; Sadler JE
Curr Opin Hematol; 2002 Sep; 9(5):389-94. PubMed ID: 12172456
[TBL] [Abstract][Full Text] [Related]
35. von Willebrand factor and thrombotic thrombocytopenic purpura.
Raife TJ; Montgomery RR
Curr Opin Hematol; 2000 Sep; 7(5):278-83. PubMed ID: 10961577
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of von Willebrand factor-cleaving protease activity in patients with thrombotic thrombocytopenic purpura.
Gao WQ; Su J; Bai X; Wang ZY; Ruan CG
Chin Med J (Engl); 2004 Jun; 117(6):818-22. PubMed ID: 15198879
[TBL] [Abstract][Full Text] [Related]
37. Comparison of von Willebrand factor antigen, von Willebrand factor-cleaving protease and protein S in blood components used for treatment of thrombotic thrombocytopenic purpura.
Yarranton H; Lawrie AS; Purdy G; Mackie IJ; Machin SJ
Transfus Med; 2004 Feb; 14(1):39-44. PubMed ID: 15043592
[TBL] [Abstract][Full Text] [Related]
38. Mild to moderate reduction of a von Willebrand factor cleaving protease (ADAMTS-13) in pregnant women with HELLP microangiopathic syndrome.
Lattuada A; Rossi E; Calzarossa C; Candolfi R; Mannucci PM
Haematologica; 2003 Sep; 88(9):1029-34. PubMed ID: 12969811
[TBL] [Abstract][Full Text] [Related]
39. Estimation of the von Willebrand factor-cleaving protease in plasma using monoclonal antibodies to vWF.
Obert B; Tout H; Veyradier A; Fressinaud E; Meyer D; Girma JP
Thromb Haemost; 1999 Nov; 82(5):1382-5. PubMed ID: 10595622
[TBL] [Abstract][Full Text] [Related]
40. [The role of von Willebrand protease in aetiopathogenesis of thrombotic thrombocytopenic purpura].
Suvajdzić-Vuković N
Srp Arh Celok Lek; 2007; 135(5-6):360-6. PubMed ID: 17633329
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
